Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This white powder compound demonstrates superior efficacy in glucose control and weight management compared to other treatments.
Our tirzepatide compound offers 99% purity and is available in various custom sizes to meet specific research requirements. The product is strictly for laboratory research use only, not for human consumption.
As a dual agonist, tirzepatide shows greater affinity to GIP receptors than GLP-1 receptors, producing enhanced reductions in hyperglycemia. The compound mimics natural GIP actions at the GIP receptor, making it valuable for metabolic research.
We offer flexible packaging options to accommodate different research needs. All products undergo rigorous quality control testing to ensure consistency and purity for research applications.
For researchers looking to buy tirzepatide compound UK, we provide pharmaceutical grade material with comprehensive analytical documentation. Our manufacturing process adheres to strict quality standards to deliver reliable research compounds.
The product is particularly valuable for studies investigating novel approaches to metabolic disorders, with potential applications in diabetes and obesity research.